The BIC International Conference is addressed to a relatively narrow selection of medical specialties since it is meant to feature only the most novel advances of basic science and clinical research in haemophilia, rare inherited coagulation disorders, von Willebrand factor and von Willebrand disease, gene therapy, the thrombotic microangiopathies and, of course, factor VIII inhibitors.
At the upcoming Conference, clinical and translational science will be again discussed from different angles. The most distinguished experts in the field will present their very latest data and offer their wisdom and insight into the current science developments.
Sponsor companies will have the opportunity of presenting their latest findings and innovations during their satellite symposia and discuss further developments with a highly competent audience.
The Joint meeting of the 10th BIC and the 3rd Inhibitors in Hemophilia International Conference was held in Italy from 6-8 September 2019.
We are glad that the Conference was highly appreciated, as you can read in the customer satisfaction report available HERE.
FULL DAYS OF PROGRAMME
WHAT WAS YOUR MAIN REASON FOR ATTENDING THE CONFERENCE?
THE CONFERENCE PROGRAMME WAS MUCH APPRECIATED FOR ITS HIGHLY INNOVATIVE SCIENTIFIC CONTENT